The joint NHS Greater Glasgow and University of Glasgow project 'Glasgow Biomedicine' is part of Medicine in Glasgow, a unique collaboration aiming to develop and promote Glasgow as an international centre of medical excellence.
The Glasgow Biomedicine project, which is supported by Scottish Enterprise Glasgow, is set to boost research and facilitate clinical trials in the city. It will attract commercial business to Glasgow and create a one-stop-shop for clinical expertise.
The trials are set to help sufferers of common diseases such as cardiovascular disease, diabetes, cancer, infectious diseases and neurological problems. The clinical trials organisation will coordinate these activities across the city, helping to deliver new treatments swiftly from laboratory bench to patient bedside.
Glasgow is set to become a world-class centre for drug development and cutting edge clinical research. The initiative will not only give the people of Glasgow access to revolutionary treatments for many diseases it will also attract large pharmaceutical and biotechnology companies and bring a number of highly skilled jobs to Scotland.
There are already 100's of trials going on in the city and the project is set to expand further on these innovative developments.
Health Minister, Andy Kerr said: "I'm delighted to attend the launch of Glasgow Biomedicine to promote the excellent standard of clinical trial work in Scotland. An expansion of our clinical trials in Scotland will not only help improve the health of our population but will also enhance the economic standing of our country. It is great to see academics, the NHS and industry working together to benefit the nation."
"I am pleased to announce an additional 12.8m to NHS research and developme
'"/>
Contact: Jenny Murray
jennifer.murray@admin.gla.ac.uk
University of Glasgow
15-Apr-2005